Thomson Medical Issues New Series of Notes
Company Announcements

Thomson Medical Issues New Series of Notes

Thomson Medical Group Ltd. (SG:A50) has released an update.

Thomson Medical Group Limited has expanded its footprint in the financial markets with the latest issuance of S$25 million in 5.50% notes due in 2028, and S$20 million in 5.25% notes due in 2027, under its S$1 billion Multicurrency Debt Issuance Programme. Both series of notes, which are set to be consolidated with existing notes, have been approved in-principle for listing on the Singapore Exchange. The move signals confidence in the company’s creditworthiness and strategic financial planning.

For further insights into SG:A50 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Singapore Auto-Generated NewsdeskThomson Medical Group Enhances Debt Portfolio
TipRanks Singapore Auto-Generated NewsdeskThomson Medical Group’s Latest Financial Snapshot
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!